BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:20251102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Eastern Standard Time TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Eastern Daylight Time TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Location: Live Webinar\nContact: Erin Matlock\nEmail: ematlock@ nvds.org\nPhone: 703/642-5297\n\nWebinar HandoutsPART 1 PART 2 PA RT 3 CLINICAL CASESONLINE CONTINUING EDUCATION**Registration Deadlin e 2/5/25**Registration was confirmed by emailRegistration is closed. Pleas e contact Erin Matlock at ematlock@nvds.org with any questions.THIS LIVE S TREAMING WEBINAR WILL INCLUDE A QUESTION &\; ANSWER SESSIONPreregistrat ion is requiredAll registrations will be confirmed by emailWebinar log-in information will be sent by email within three(3) business daysEach r egistrant must have a unique email addressAttendees will receive their CE certificate by email three(3) business days after the webinarThe webi nar will be recorded and available on demand for credit on the NVDS websit e by Monday 2/10/25.Synopsis:Pediatric sleep apnea is a very frequent cond ition affecting 3-5% of all children. This presentation will focus on the clinical presentation of sleep apnea in children including the various ph enotypic variants that have been identified to date\, approaches to the di agnosis of the disease that extend being overnight polysomnography\, and d escription of some of the more important end-organ morbid consequences of sleep apnea in children. The second presentation will then encompass an i mproved understanding on the pathophysiology of morbidity in sleep apnea i n general. In addition to well-stablished processes such as inflammation\, autonomic nervous system imbalances and remodeling\, the lecture will als o focus on novel mechanisms encompassing gut microbiome\, senescence and b lood brain barrier permeability.* Part #1: Clinical Presentation\, Pathop hysiological Considerations and Diagnostic Approaches* Part #2: End-Organ Morbidity and its Mechanisms\, As Drivers of Phenotypic VarianceCourse Obj ectives:To enable the audience to recognize symptoms and signs associated with an increased risk of sleep apnea in children.To identify the various diagnostic modalities\, their advantages and limitations.To recognize phen otypic variance and the potential mechanisms driving morbid consequences o f sleep apnea. About Our Presenter:Dr. Gozal is currently the Dean of the Joan C. Edwards School of Medicine and Vice President for Health Affairs o f Marshall University in Huntington\, West Virginia. Dr. Gozal’s research interests include projects such as gene and cellular regulation in hypoxia and sleep disruption\, murine models of sleep disorders\, and genomic and proteomic approaches to clinical and epidemiological aspects of sleep apn ea in both adults and children. In addition\, he has pioneered biomarker d iscovery and machine learning approaches for the diagnosis of sleep apnea across the lifespan. More recently\, he has begun exploration of the role of the gut microbiome and circulating exosomes as mechanistic effectors an d biomarkers in sleep disorders and associated morbidities.He is Past Pres ident of the American Thoracic Society\, the world leading organization fo r pulmonary\, critical are and sleep medicine\, was a member of the Board of Directors of the Sleep Research Society 2014-2016 and is Deputy Editor- in-Chief for the journal Sleep\, and Associate Editor for ERJ\, Pediatric Pulmonology\, and Frontiers in Neurology and Frontiers in Psychiatry. He h as been the recipient of the ATS Amberson Lecture in 2002 and was awarded the William C. Dement Academic Achievement Award by the American Academy o f Sleep Medicine in 2013\, and the 2016 Lifetime Achievement Award of the National Sleep Foundation. He has also received two honorary doctorates fr om the University of Barcelona and University of Lleida in Spain. His rese arch work has been continuously supported by grants from the NIH since 199 2\, and he has published over 850 peer-reviewed original articles carrying a H index of 137 and >\;80\,000 citations along with nearly 200 book ch apters and reviews\, edited 7 books\, presented more than 1\,000 scientifi c abstracts\, and has extensively lectured all over the world.The Northern Virginia Dental Society is an ADA CERP Recognized Provider.ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors\, nor does i t imply acceptance of credit hours by boards of dentistry. See each course description for the number of continuing education credits designated by the Northern Virginia Dental Society. DTEND:20250207T170000Z DTSTAMP:20260513T213433Z DTSTART:20250207T140000Z LOCATION: SEQUENCE:0 SUMMARY:NVDS ONLINE CE PROGRAM – “Pediatric Sleep Apnea” with David Gozal\, MD\, MBA\, PhD UID:RFCALITEM639143048730976316 X-ALT-DESC;FMTTYPE=text/html:Location: Live Webinar
Contact: Erin Matlock
Email: ematlock@nvds.org
Phone: 7 03/642-5297

Webinar Handouts

PART 1  \;  \; PART 2 \;  \;  \; PART 3 \;  \;  \; CLINICAL CASES

ONLINE CONTINUING EDUCATION

**Registration Deadline 2/5/25**

Registration was confirmed by email

Registration is closed.

Please contact Erin Matlock at& nbsp\;ematlock@nvds.org \;with any questions.

THIS LIVE STREAMING WEBINAR WILL INCLUD E A QUESTION &\; ANSWER SESSION

The webinar will be recorded and available on demand for credit

on the NVDS website by Monday 2/10/25.

Synopsis:
< /p>

Pediatric sleep apnea is a very frequent condition affect ing 3-5% of all children. \; This presentation will focus on the clini cal presentation of sleep apnea in children including the various phenotyp ic variants that have been identified to date\, approaches to the diagnosi s of the disease that extend being overnight polysomnography\, and descrip tion of some of the more important end-organ morbid consequences of sleep apnea in children. \; The second presentation will then encompass an i mproved understanding on the pathophysiology of morbidity in sleep apnea i n general. In addition to well-stablished processes such as inflammation\, autonomic nervous system imbalances and remodeling\, the lecture will als o focus on novel mechanisms encompassing gut microbiome\, senescence and b lood brain barrier permeability.

* Part #1: Clinical Presentatio n\, \; Pathophysiological Considerations and Diagnostic Approaches

* Part #2: End-Organ Morbidity and its Mechanisms\, As Drivers of Phenotypic Variance

Course Objectives:

  • To enable the audience to recognize symptoms and signs associated with an increased risk of sleep apnea in children.
  • To identify the various diagnostic modalities\, their advantages and limitati ons.
  • To recognize phenotypic variance and the potential mechanisms driving morbid consequences of sleep apnea.

Abou t Our Presenter:

Dr. Gozal is currently the Dean of the J oan C. Edwards School of Medicine and Vice President for Health Affairs of Marshall University in Huntington\, West Virginia. Dr. Gozal’s research i nterests include projects such as gene and cellular regulation in hypoxia and sleep disruption\, murine models of sleep disorders\, and genomic and proteomic approaches to clinical and epidemiological aspects of sleep apne a in both adults and children. In addition\, he has pioneered biomarker di scovery and machine learning approaches for the diagnosis of sleep apnea a cross the lifespan. More recently\, he has begun exploration of the role o f the gut microbiome and circulating exosomes as mechanistic effectors and biomarkers in sleep disorders and associated morbidities.
He is Past President of the American Thoracic Society\, the world leading organ ization for pulmonary\, critical are and sleep medicine\, was a member of the Board of Directors of the Sleep Research Society 2014-2016 and is Depu ty Editor-in-Chief for the journal Sleep\, and Associate Editor for ERJ\, Pediatric Pulmonology\, and Frontiers in Neurology and Frontiers in Psychi atry. He has been the recipient of the ATS Amberson Lecture in 2002 and wa s awarded the William C. Dement Academic Achievement Award by the American Academy of Sleep Medicine in 2013\, and the 2016 Lifetime Achievement Awa rd of the National Sleep Foundation. He has also received two honorary doc torates from the University of Barcelona and University of Lleida in Spain . His research work has been continuously supported by grants from the NIH since 1992\, and he has published over 850 peer-reviewed original article s carrying a H index of 137 and >\;80\,000 citations along with nearly 2 00 book chapters and reviews\, edited 7 books\, presented more than 1\,000 scientific abstracts\, and has extensively lectured all over the world.
The Northern Virginia Dental Society is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist den tal professionals in identifying quality providers of continuing dental ed ucation. ADA CERP does not approve or endorse individual courses or instru ctors\, nor does it imply acceptance of credit hours by boards of dentistr y. See each course description for the number of continuing education cred its designated by the Northern Virginia Dental Society. \;


END:VEVENT END:VCALENDAR